Margaret McLoughlin, Director of Quince Therapeutics QNCX, has filed 1 purchase and 0 sales on the open market. The latest trade was on 01/02.

MM

MM

Margaret McLoughlin

Director

Company

Quince Therapeutics QNCX

First filing

23/05/26

Trades

6 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

01/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Quince TherapeuticsQNCX	Open-market buy	23/08/08	23/08/09	8,000 sh	$1.23	$9,840	No record